drugset / Trial / NCT01167764

Effect of Tranexamic Acid on Prevention of Recurrence of Hemoptysis

NCT01167764

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Hemoptysis is one of the serious complication of many pulmonary diseases. Upto now, there is no proven medical treatment in recurrence of hemoptysis. The investigators will conduct a randomized, placebo controlled trial of tranexamic acid, which can reduce the recurrence of hemoptysis.

Timeline

Start
2011-07
Primary completion
2013-07
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 250 mg Oral

Indications

No indication recorded.